In today’s recent session, 0.71 million shares of the 89bio Inc (NASDAQ:ETNB) have been traded, and its beta is 1.49. Most recently the company’s share price was $9.10, and it changed around -$0.39 or -4.11% from the last close, which brings the market valuation of the company to $1.33B. ETNB at last check was trading at a discount to its 52-week high of $11.84, offering almost -30.11% off that amount. The share price’s 52-week low was $4.16, which indicates that the recent value has risen by an impressive 54.29% since then. We note from 89bio Inc’s average daily trading volume that its 10-day average is 2.37 million shares, with the 3-month average coming to 2.01 million.
89bio Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.36. If we narrow it down even further, the data shows that 0 out of 11 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 2 recommended ETNB as a Hold, whereas 8 deemed it a Buy, and 0 rated it as Underweight. 89bio Inc is expected to report earnings per share of -0.48 for the current quarter.
89bio Inc (NASDAQ:ETNB) trade information
Instantly ETNB has been showing red trend so far today with a performance of -4.11% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 10.26 on recent trading dayincreased the stock’s daily price by 11.31%. The company’s shares are currently up 16.37% year-to-date, but still up 18.18% over the last five days. On the other hand, 89bio Inc (NASDAQ:ETNB) is 31.12% up in the 30-day period. We can see from the shorts that 17.31 million shares have been sold at a short interest cover period of 9.2 day(s).
The consensus price target as assigned by Wall Street analysts is $25, which translates to bulls needing to increase their stock price by 63.6% from its current value. Analyst projections state that ETNB is forecast to be at a low of $12 and a high of $29.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 32.21%. 89bio Inc earnings are expected to increase by 40.30% in 2025, but the outlook is positive 16.04% per year for the next five years.
ETNB Dividends
89bio Inc’s next quarterly earnings report is expected to be released on 2025-Apr-30.
89bio Inc (NASDAQ:ETNB)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.63% of 89bio Inc shares, and 108.89% of them are in the hands of institutional investors. The stock currently has a share float of 109.58%. 89bio Inc stock is held by 258.0 institutions, with RA CAPITAL MANAGEMENT, L.P. being the largest institutional investor. By 2024-06-30, it held 14.1994% of the shares, which is about 14.18 million shares worth $113.54 million.
JANUS HENDERSON GROUP PLC, with 13.2986% or 13.28 million shares worth $106.32 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 3.08 shares worth $27.96 million, making up 2.11% of all outstanding shares. On the other hand, JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund held roughly 2.97 shares worth around $26.95 million, which represents about 2.03% of the total shares outstanding.
